Australian (ASX) Growth Pharmaceuticals & Biotech Stocks

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
BOT Botanix Pharmaceuticals	AU$0.35	-7.8%	153.6%	AU$651.6m	n/a	PS1469.7x	E122.3%	n/a
ACR Acrux	AU$0.07	6.1%	42.9%	AU$19.8m	n/a	PS1.8x	E115.3%	0%
LGP Little Green Pharma	AU$0.10	0%	-42.9%	AU$29.3m	n/a	PS1.2x	E110.1%	n/a
MYX Mayne Pharma Group	AU$4.72	6.3%	0.9%	AU$379.8m	AU$6.89	PS1.2x	E99.8%	n/a
ARX Aroa Biosurgery	AU$0.62	2.5%	-33.3%	AU$210.0m	n/a	PS3.4x	E99.2%	n/a
MVP Medical Developments International	AU$0.49	3.2%	-62.3%	AU$41.0m	AU$3.66	PS1.3x	E83.4%	0%
GSS Genetic Signatures	AU$0.77	1.3%	17.6%	AU$172.2m	AU$1.10	PS10.9x	E80.1%	n/a
TRJ Trajan Group Holdings	AU$1.04	4.0%	-45.1%	AU$147.6m	AU$1.15	PB1.3x	E77.4%	n/a
BDX BCAL Diagnostics	AU$0.13	-10.3%	85.7%	AU$39.3m	n/a	PS11x	E60.0%	n/a
OPT Opthea	AU$0.39	2.7%	-30.6%	AU$467.8m	n/a	PS805.1x	E54.0%	n/a
IMU Imugene	AU$0.06	9.1%	-34.8%	AU$411.6m	n/a	PS29.3x	E50.7%	n/a
CU6 Clarity Pharmaceuticals	AU$6.37	8.9%	628.0%	AU$1.9b	AU$5.30	PS209.3x	E49.3%	n/a
MSB Mesoblast	AU$1.31	10.6%	8.3%	AU$1.3b	AU$1.25	PS132.3x	E48.8%	n/a
IMM Immutep	AU$0.30	1.7%	-4.7%	AU$420.2m	n/a	PS110.5x	E40.1%	n/a
TLX Telix Pharmaceuticals	AU$20.31	1.9%	81.0%	AU$6.6b	AU$20.87	PE214.6x	E37.8%	n/a
PIQ Proteomics International Laboratories	AU$0.94	-3.1%	6.8%	AU$119.9m	n/a	PS40.6x	E37.2%	n/a
CYP Cynata Therapeutics	AU$0.24	-2.0%	69.0%	AU$45.8m	AU$1.22	PS18.3x	E35.6%	n/a
RAD Radiopharm Theranostics	AU$0.038	2.7%	-65.5%	AU$40.2m	n/a	PS6.7x	E28.7%	n/a
CUV Clinuvel Pharmaceuticals	AU$15.20	-1.6%	-17.5%	AU$763.7m	AU$30.33	PE25.2x	E26.8%	0.3%
PAR Paradigm Biopharmaceuticals	AU$0.29	-3.3%	-69.0%	AU$103.4m	n/a	PS2416.3x	E20.4%	n/a
SNT Syntara	AU$0.039	-15.2%	-32.8%	AU$47.8m	n/a	PS2.4x	E17.3%	n/a
CSL CSL	AU$312.15	1.4%	17.6%	AU$149.4b	AU$316.57	PE40.5x	E13.8%	1.1%
NEU Neuren Pharmaceuticals	AU$20.87	-0.6%	48.5%	AU$2.6b	AU$28.68	PE17x	E3.4%	n/a
ILA Island Pharmaceuticals	AU$0.068	0%	-32.0%	AU$8.5m	n/a	PS9x	E0.8%	n/a